Stockreport

Multiple Sclerosis Drug Pipeline Research Report 2024: Therapeutic Assessment, Emerging Drugs, Pipeline Development Activities, Competitive Landscape [Yahoo! Finance]

Immunic, Inc.  (IMUX) 
PDF The assessment part of the report embraces, in depth Multiple Sclerosis commercial assessment and clinical assessment of the pipeline products under development. In the [Read more]